Renovia Names General Counsel and Senior Vice President, Strategic Development

Renovia Inc., a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, has promoted Jim O’Connor to general counsel and senior vice president, Strategic Development, effective immediately.
 
O’Connor joined Renovia as general counsel in February 2018 and since then has led the company’s legal, compliance, quality and regulatory functions. In his new role, O’Connor’s responsibilities will expand to include corporate business development, manufacturing, program management and overseeing Renovia’s finance team. He will also assist in identifying and implementing programs to improve organizational efficiency and execution.
 
“Jim has shown remarkable judgment and versatility, and has become a key cross-functional leader,” said Marc Beer, co-founder, chairman and CEO of Renovia. “In his Strategic Development role, Jim will partner with the entire Renovia team to develop and implement strategies to maximize return on investments across our technology portfolio. As Renovia continues its growth and prepares for commercial launch of our next-generation digital therapeutics, he will also help drive potential business development and partnership opportunities.”

Prior to joining Renovia, O’Connor worked for 12 years at United Technologies Corp. (UTC), a Fortune 100 company, in legal and business roles of increasing responsibility. O’Connor began his legal career at Testa, Hurwitz & Thibeault, where his practice focused on securities law, mergers and acquisitions and licensing transactions for private and publicly traded technology companies. O’Connor earned a bachelor of arts degree from Boston College and his Juris Doctor from Cornell Law School in 1999.
 
“I am fortunate to work with the teams across Renovia and honored to take on this broader leadership role,” stated O’Connor. “I look forward to working closely with Marc and everyone at Renovia as we leverage our pipeline of digital therapeutic and diagnostic devices to help create a new standard of care in women’s health.”
 
Renovia was formed to develop and commercialize products for better first-line diagnosis and treatment to improve the condition-specific quality of life for millions of women with pelvic floor disorders. Renovia’s technology enables treatment via precise visualization of pelvic movement in real-time during pelvic floor muscle training, while monitoring usage and progress over time. As a women’s health organization, Renovia is in pursuit of scalable and cost-effective care for pelvic floor disorders delivered through the power of digital health.